Showing results (1-10 of 310) with videos related to

Sort By:
Pageof 31
Plos One|May 21, 2014
Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of LupusEdmund A Rossi, Chien-Hsing Chang, David M Goldenberg
Bioconjugate Chemistry|December 16, 2011
The dock-and-lock method combines recombinant engineering with site-specific covalent conjugation to generate multifunctional structuresEdmund A Rossi, David M Goldenberg, Chien-Hsing Chang
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
The dock and lock method: a novel platform technology for building multivalent, multifunctional structures of defined composition with retained bioactivityChien-Hsing Chang, Edmund A Rossi, David M Goldenberg
Trends in Pharmacological Sciences|June 29, 2012
Complex and defined biostructures with the dock-and-lock methodEdmund A Rossi, David M Goldenberg, Chien-Hsing Chang
Blood|July 15, 2010
Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemiasPankaj Gupta, David M Goldenberg, Edmund A Rossi, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 2, 2010
Improved cancer therapy and molecular imaging with multivalent, multispecific antibodiesRobert M Sharkey, Edmund A Rossi, Chien-Hsing Chang, et al.
Biotechnology Progress|April 8, 2011
A new mammalian host cell with enhanced survival enables completely serum-free development of high-level protein production cell linesDiane L Rossi, Edmund A Rossi, David M Goldenberg, et al.
Bioconjugate Chemistry|November 3, 2012
Optimization of multivalent bispecific antibodies and immunocytokines with improved in vivo propertiesEdmund A Rossi, Chien-Hsing Chang, Thomas M Cardillo, et al.
Blood|August 28, 2009
CD20-targeted tetrameric interferon-alpha, a novel and potent immunocytokine for the therapy of B-cell lymphomasEdmund A Rossi, David M Goldenberg, Thomas M Cardillo, et al.
Plos One|May 23, 2013
Interferon-λ1 linked to a stabilized dimer of Fab potently enhances both antitumor and antiviral activities in targeted cellsDonglin Liu, Chien-Hsing Chang, Edmund A Rossi, et al.
Pageof 31